Share Requisition # HRC0574820 A postdoctoral Scientist position is available immediately to study Nod-like Receptor (NLR), AIM2-like receptor (ALR) and type I interferon signaling in the Stehlik-Dorfleutner Laboratory of Molecular Innate Immunology at the Cedars Sinai Medical Center in Los Angeles, California. Research is focused on the molecular mechanisms regulating inflammasome and type I interferon-linked innate immune signaling pathways in myeloid cells and their function in inflammatory and auto-immune disease and during host-pathogen interaction in humans and mouse models. More information can be found at https://www.cedars-sinai.org/research/labs/stehlik-dorfleutner-lab.html The Stehlik-Dorfleutner lab is located in the Department of Academic Pathology at the Cedars-Sinai Medical Center, a major nonprofit academic healthcare organization. Whether you love world-class entertainment, dining, shopping and museums or prefer the outdoors and sports, Los Angeles has something for everyone. Year-round sunshine provides the perfect backdrop for endless activities. Centrally located in the middle of everything is Cedars-Sinai. Working and living here, you are never far from something new and exciting. Our laboratory consists of modern research space with state of the art equipment and provides a highly collaborative work environment. We are looking for an enthusiastic individual with a positive attitude towards challenging projects, who seeks the opportunity to succeed in a productive environment with excellent facilities. This position is available for a one-year appointment with the expected possibility of extension and offers exceptional salary and benefits. Educational requirement: Doctorate (MD, PhD, PhD/MD) in area directly related to field of research specialization Experience: Applicants need to be self-driven, highly motivated recent Graduates with a PhD, MD/PhD or MD degree and a strong background in innate immunology or biochemistry and animal models as demonstrated by first-author publications in internationally-recognized scientific journals. Applicants with experience in biochemical techniques and immune-relevant animal models will receive special consideration. The ability to work in a team, good organizational and English language skills, as well as initiative, flexibility and good learning ability are required. Working Title: Postdoctoral Scientist – Department of Academic Pathology – Stehlik Lab Department: Pathology Group Operations Business Entity: Academic / Research City: Los Angeles Job Category: Academic/Research Job Specialty: Postdoctoral Position Type: Full-time Shift Length: 8 hour shift Shift Type: Day Cedars-Sinai is an EEO employer. Cedars-Sinai does not unlawfully discriminate on the basis of the race, religion, color, national origin, citizenship, ancestry, physical or mental disability, legally protected medical condition (cancer-related or genetic characteristics or any genetic information), marital status, sex, gender, sexual orientation, gender identity, gender expression, pregnancy, age (40 or older), military and/or veteran status or any other basis protected by federal or state law. If you need a reasonable accommodation for any part of the employment process, please contact us by email at Applicant_Accommodation@cshs.org and let us know the nature of your request and your contact information. Requests for accommodation will be considered on a case-by-case basis. Please note that only inquiries concerning a request for reasonable accommodation will be responded to from this email address. Cedars-Sinai will consider for employment qualified applicants with criminal histories, in accordance with the Los Angeles Fair Chance Initiative for Hiring. At Cedars-Sinai, we are dedicated to the safety, health and wellbeing of our patients and employees. This includes protecting our patients from communicable diseases, such as influenza (flu). For this reason, we require that all new employees receive a flu vaccine based on the seasonal availability of flu vaccine (typically during September through March each year) as a condition of employment, and annually thereafter as a condition of continued employment.